Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.
Ruan J, Moskowitz A, Mehta-Shah N, Sokol L, Chen Z, Kotlov N, Nos G, Sorokina M, Maksimov V, Sboner A, Sigouros M, van Besien K, Horwitz S, Rutherford SC, Mulvey E, Revuelta MV, Xiang J, Alonso A, Melnick A, Elemento O, Inghirami G, Leonard JP, Cerchietti L, Martin P.
Ruan J, et al. Among authors: moskowitz a.
Blood. 2023 May 4;141(18):2194-2205. doi: 10.1182/blood.2022018254.
Blood. 2023.
PMID: 36796016
Free PMC article.
Clinical Trial.